Search for: "Garner v. Blue Cross and Blue Shield Association et al"
Results 1 - 1
of 1
Sorted by Relevance
|
Sort by Date
12 Aug 2022, 4:24 am
Most payors still include Fluid Flow on their experimental and investigational list for all orthopedic conditions.[9] As policies are updated, some payors, like Blue Cross Blue Shield of Rhode Island,[10] are considering some uses of the product as medically reasonable. [read post]
